PMC10351526_01
(A) Design of the 18-month clinical study. After subjects' preselection between days -120 and 0, the selected ones were injected at D0. The investigators who performed the injections carried out the 7 evaluation follow-up visits. (B) Anatomical zones of injection by the filler and the related maximal volumes.
CCID-16-1795-g0001.jpg
PMC10351526_01_CCID-16-1795-g0001.jpg
f0001
The selected subjects were informed about the study process (Figure 1A). The volume of product injected was adapted to the corrected area, but a maximum of 1.2 mL each side was authorized to be injected for the nasolabial folds, 1.2 mL each side for the marionette lines, and 1.0 mL for the lips (Figure 1B).